Insmed Gene Therapy LLC
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Insmed Gene Therapy LLC
RECRUITINGPhase 1NCT07290062
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in...
The primary objective of this dose-finding study is to evaluate the safety, tolerability and pharmacodynamics of single dose of INS1202 via IT administration in participants ≥ 18...
Sponsor: Insmed Gene Therapy LLCEnrolling: 233 locations
Amyotrophic Lateral Sclerosis
RECRUITINGPhase 1NCT06817382
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory...
The primary objective of this study is to evaluate the safety and tolerability of a single dose of INS1201 via IT administration in ambulatory male participants with DMD.
Sponsor: Insmed Gene Therapy LLCEnrolling: 129 locations
Duchenne Muscular Dystrophy